| An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells F González, Z Zhu, ZD Shi, K Lelli, N Verma, QV Li, D Huangfu Cell stem cell 15 (2), 215-226, 2014 | 535 | 2014 |
| CRISPR/Cas9-based engineering of the epigenome J Pulecio, N Verma, E Mejía-Ramírez, D Huangfu, A Raya Cell stem cell 21 (4), 431-447, 2017 | 277 | 2017 |
| TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells N Verma, H Pan, LC Doré, A Shukla, QV Li, B Pelham-Webb, V Teijeiro, ... Nature genetics 50 (1), 83-95, 2018 | 176 | 2018 |
| Genome editing in hPSCs reveals GATA6 haploinsufficiency and a genetic interaction with GATA4 in human pancreatic development ZD Shi, K Lee, D Yang, S Amin, N Verma, QV Li, Z Zhu, CL Soh, R Kumar, ... Cell stem cell 20 (5), 675-688. e6, 2017 | 160 | 2017 |
| Genome-scale screens identify JNK–JUN signaling as a barrier for pluripotency exit and endoderm differentiation QV Li, G Dixon, N Verma, BP Rosen, M Gordillo, R Luo, C Xu, Q Wang, ... Nature genetics 51 (6), 999-1010, 2019 | 106 | 2019 |
| A CRISPR/Cas-mediated selection-free knockin strategy in human embryonic stem cells Z Zhu, N Verma, F González, ZD Shi, D Huangfu Stem cell reports 4 (6), 1103-1111, 2015 | 104 | 2015 |
| QSER1 protects DNA methylation valleys from de novo methylation G Dixon, H Pan, D Yang, BP Rosen, T Jashari, N Verma, J Pulecio, ... Science 372 (6538), eabd0875, 2021 | 78 | 2021 |
| DICER1 is essential for self-renewal of human embryonic stem cells V Teijeiro, D Yang, S Majumdar, F González, RW Rickert, C Xu, R Koche, ... Stem cell reports 11 (3), 616-625, 2018 | 29 | 2018 |
| CRISPR/Cas-mediated knockin in human pluripotent stem cells N Verma, Z Zhu, D Huangfu Cancer Gene Networks, 119-140, 2017 | 21 | 2017 |
| Consolidative thoracic radiation therapy after first-line chemotherapy and immunotherapy in extensive-stage small cell lung cancer: a multi-institutional case series BH Diamond, N Verma, UC Shukla, HS Park, PP Koffer Advances in Radiation Oncology 7 (2), 100883, 2022 | 18 | 2022 |
| Prognostic significance of human papillomavirus and Epstein‐Bar virus in nasopharyngeal carcinoma N Verma, S Patel, V Osborn, S McBride, N Riaz, A Lee, N Katabi, ... Head & neck 42 (9), 2364-2374, 2020 | 18 | 2020 |
| Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation Y Lan, KM Banks, H Pan, N Verma, GR Dixon, T Zhou, B Ding, ... Cell Reports 37 (10), 2021 | 17 | 2021 |
| Sildenafil citrate improves erectile function after castration in a rat model JP Mulhall, N Verma, S Deveci, R Tal, K Kobylarz, A Müller BJU international 113 (4), 656-661, 2014 | 14 | 2014 |
| Predicting radiation dosimetric distribution in different regions of the jaw in patients receiving radiotherapy for squamous cell carcinoma of the tonsil CJ Tsai, N Verma, AA Owosho, P Hilden, J Leeman, SH Yom, JM Huryn, ... Head & neck 41 (10), 3604-3611, 2019 | 7 | 2019 |
| Intramedullary spinal cord and leptomeningeal metastases from intracranial low-grade oligodendroglioma N Verma, C Nolan, M Hirano, RJ Young Clinical imaging 38 (4), 505-507, 2014 | 7 | 2014 |
| Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft‐Tissue Sarcoma in a National Cohort JK Kim, N Verma, S McBride, N Riaz, JO Boyle, D Spielsinger, C Sabol, ... The Laryngoscope 130 (1), 120-127, 2020 | 4 | 2020 |
| Parallel genome-scale CRISPR screens distinguish pluripotency and self-renewal BP Rosen, QV Li, H Cho, D Liu, D Yang, S Graff, J Yan, R Luo, N Verma, ... bioRxiv, 2023.05. 03.539283, 2023 | 1 | 2023 |
| A detailed observational study of maternal and neonatal variables affecting the thyroid-stimulating hormone levels in neonates NR Verma, G Naik, S Patel, P Padhi, T Naik, R Nanda Egyptian Pediatric Association Gazette 69, 1-9, 2021 | 1 | 2021 |
| Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy N Verma, JH Laird, NS Moore, TJ Hayman, N Housri, GW Peters, ... Advances in Radiation Oncology 9 (6), 101500, 2024 | | 2024 |
| Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy N Verma, PA Renauer, C Dong, S Xin, Q Lin, F Zhang, PM Glazer, S Chen bioRxiv, 2024 | | 2024 |
